Average Cost of Care in Year After Ovarian Cancer Surgery ~$100K

Share this content:
Average Cost of Care in Year After Ovarian Cancer Surgery ~$100K
Average Cost of Care in Year After Ovarian Cancer Surgery ~$100K

WEDNESDAY, Nov. 8, 2017 (HealthDay News) -- For women with ovarian cancer who underwent both surgery and adjuvant chemotherapy, the average medical expenditures are about $100,000 in the first year after surgery, according to a study published online Nov. 7 in Obstetrics & Gynecology.

Alexandra S. Bercow, M.D., from Columbia University College of Physicians and Surgeons in New York City, and colleagues conducted a retrospective cohort study of women with ovarian cancer diagnosed from 2009 to 2012 who underwent both surgery and adjuvant chemotherapy. Medical expenditures were estimated for a 12-month period beginning on the date of surgery; all payments, including out-of-pocket costs, were examined. Data were included for 5,031 women after exclusion of patients with incomplete insurance enrollment or coverage, those who did not undergo chemotherapy, and those with capitated plans.

The researchers found that during the first year after the index procedure, the median total medical expenditures per patient were $93,632. Inpatient services accounted for 37.8 percent in expenditures ($30,708); outpatient services for 58.3 percent ($52,700); and outpatient drug costs for 3.8 percent ($1,814). The median out-of-pocket expense was $2,998, which included $1,509, $589, and $351 for outpatient services, inpatient services, and outpatient drug costs, respectively.

"The average cost of care for women with ovarian cancer in the first year after surgery is approximately $100,000. Patients bear approximately 3 percent of these costs in the form of out-of-pocket expenses," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »